We are pleased to announce that Blue Latitude Health has won a PMEA 2015 award for our work with Eli Lilly and Company on the Lilly Medical Information Cascade. The project was shortlisted in two categories, ‘Excellence in Physicians/Healthcare Provider Support Programmes’ and ‘Innovation’, winning in Innovation
Blue Latitude Health announce, on World Stroke Day, the launch of Sign Against Stroke a patient and carer centric website for people impacted by AF, developed by the Sign Against Stroke Task Force to empower patients and their family members.
Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated. A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact.
Senior Account Manager Dolan Desai talks us through the five core considerations that will allow you to maximise impact across a region through coherent execution.
Head of Insight Martine gives a first-hand perspective of what it’s like to live with cancer, and additional insight into what it means to be a cancer patient. This is the second instalment of a three part series about living with breast cancer.
We are pleased to announce that we have been shortlisted for not one, but two PMEA 2015 awards for our Lilly Medical Information Cascade project. We were shortlisted in the Excellence in Physicians/Healthcare Provider Support Programmes category, as well as the Innovation category.
By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Head of Insight Martine Leroy delivers her top tips on how to keep insight at the centre of your positioning to best support your brand.
Blue Latitude Health is a healthcare creative marketing consultancy, and part of our day-to-day work involves working closely with oncology healthcare professionals and patients to understand their experiences. And we care deeply about the work of charities that support cancer research, patients and families. Together, as the self-appointed ‘Maggie’s Blues’, Kavita and Martine took part in the Culture Crawl London event organised by Maggie’s Centres, a UK-based cancer support charity organisation that does make an incredible difference to patients and their families.
For many years, pharma have reduced the impact of loss of exclusivity (LOE) by launching alternative molecules to treat the same condition. Whilst the commercial intention of this is to maximise the value gained from a therapy area, the execution of a portfolio strategy can impact this if done poorly. With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.
Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.
Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.
We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas.